These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes. Yang EY; Khan MA; Graviss EA; Nguyen DT; Bhimaraj A; Nambi V; Hoogeveen RC; Ballantyne CM; Zoghbi WA; Shah DJ Sci Rep; 2019 Dec; 9(1):20168. PubMed ID: 31882822 [TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257 [TBL] [Abstract][Full Text] [Related]
4. Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis. Marques MD; Weinberg R; Kapoor S; Ostovaneh MR; Kato Y; Liu CY; Shea S; McClelland RL; Post WS; Bluemke DA; Lima JAC; Ambale-Venkatesh B Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1407-1416. PubMed ID: 35147665 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging. Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients. Chaikriangkrai K; Abbasi MA; Sarnari R; Dolan R; Lee D; Anderson AS; Ghafourian K; Khan SS; Vorovich EE; Rich JD; Wilcox JE; Blaisdell JA; Yancy CW; Carr J; Markl M JACC Cardiovasc Imaging; 2020 Jul; 13(7):1521-1530. PubMed ID: 32199848 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. Cadour F; Quemeneur M; Biere L; Donal E; Bentatou Z; Eicher JC; Roubille F; Lalande A; Giorgi R; Rapacchi S; Cortaredona S; Tradi F; Bartoli A; Willoteaux S; Delahaye F; Biene SM; Mangin L; Ferrier N; Dacher JN; Bauer F; Leurent G; Lentz PA; Kovacsik H; Croisille P; Thuny F; Bernard M; Guye M; Furber A; Habib G; Jacquier A J Cardiovasc Magn Reson; 2023 Feb; 25(1):7. PubMed ID: 36747201 [TBL] [Abstract][Full Text] [Related]
9. Quantitating myocardial fibrosis using extracellular extravascular volume determined from computed tomography myocardial perfusion imaging. Li N; Zhang X; Gu J; Yang M; Chen L; Yu J; Shi H BMC Med Imaging; 2024 Feb; 24(1):40. PubMed ID: 38347469 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification in patients with structurally normal hearts: Does fibrosis type matter? Gil KE; Mikrut K; Mazur J; Black AL; Truong VT; Smart S; Zareba KM PLoS One; 2023; 18(12):e0295519. PubMed ID: 38117807 [TBL] [Abstract][Full Text] [Related]
11. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy. Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine. Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490 [TBL] [Abstract][Full Text] [Related]
13. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study. Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432 [TBL] [Abstract][Full Text] [Related]
14. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. Neilan TG; Mongeon FP; Shah RV; Coelho-Filho O; Abbasi SA; Dodson JA; McMullan CJ; Heydari B; Michaud GF; John RM; Blankstein R; Jerosch-Herold M; Kwong RY JACC Cardiovasc Imaging; 2014 Jan; 7(1):1-11. PubMed ID: 24290570 [TBL] [Abstract][Full Text] [Related]
15. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Wang S; Hu H; Lu M; Sirajuddin A; Li J; An J; Chen X; Yin G; Lan T; Dai L; Zhang Y; Yin X; Song L; Dang A; Kellman P; Arai AE; Zhao S Eur Radiol; 2017 Nov; 27(11):4620-4630. PubMed ID: 28439652 [TBL] [Abstract][Full Text] [Related]
16. Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major. Meloni A; Pistoia L; Positano V; De Luca A; Martini N; Spasiano A; Fotzi I; Bitti PP; Visceglie D; Alberini G; Sinagra G; Pepe A; Cademartiri F Eur Radiol; 2023 Feb; 33(2):1266-1276. PubMed ID: 36066735 [TBL] [Abstract][Full Text] [Related]
17. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361 [TBL] [Abstract][Full Text] [Related]
18. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis. Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252 [TBL] [Abstract][Full Text] [Related]
20. Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance Imaging. Garg P; Broadbent DA; Swoboda PP; Foley JRJ; Fent GJ; Musa TA; Ripley DP; Erhayiem B; Dobson LE; McDiarmid AK; Haaf P; Kidambi A; van der Geest RJ; Greenwood JP; Plein S Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28674085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]